Promentis Pharmaceuticals
Promentis Pharmaceuticals is a biotech company in Milwaukee, United States, founded in 2007. It has raised $30.8M across 3 rounds, most recently a $26.0M Series C in March 2017.
Seeking to redefine what is possible
- Headquarters
- Milwaukee, Wisconsin
- Employees
- 1–10
- Founded
- 2007
- Business Model
- B2B
- Website
- promentispharma.com
- Total Funding
- $30.8M
- Last Round
- $26.0M Series CMar 2017
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.
About
Promentis Pharmaceuticals is a privately held, clinical-stage biopharmaceutical company based in Milwaukee, Wisconsin, developing novel oral small-molecule therapies for neuropsychiatric disorders. The company's platform is built around System xc-, a cystine/glutamate antiporter that modulates glutamate signaling in brain circuits implicated in urge control and executive function. Promentis's lead program targets trichotillomania — a highly prevalent obsessive-compulsive spectrum disorder for which no FDA-approved therapy exists — and has advanced into Phase 2 clinical trials. The company's broader pipeline applies the same glutamatergic mechanism to other obsessive-compulsive, addictive, and CNS disorders. Promentis was co-founded by neuroscientists from Marquette University and the Medical College of Wisconsin, including Drs. John Mantsch and David Baker.
Summary
It lists 1–10 employees. It has raised $30.8M in total across 3 rounds, most recently a $26.0M Series C round in Mar 2017. Investors include OrbiMed, F-Prime Capital and Aisling Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2017
Sign up to see all 3 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/promentis-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/promentis-pharmaceuticals" alt="Promentis Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>